BOTHELL, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (NYSE Amex: DDD) today announced that on June 25, 2009 it received notice from the NYSE Amex LLC that the Company is not in compliance with Section 1003(a)(iii) of the NYSE Amex Company Guide with stockholders’ equity of less than $6,000,000 and losses from continuing operations and net losses in its five most recent fiscal years.
